Pharmaceutical Manufacturers Rapidly Adopt Validated Seal Formats
Pharmaceutical and medical manufacturers pursuing sealing compliance and barrier integrity credibility are increasingly specifying validated heat sealable films with documented seal strength and barrier testing, rather than the conventional cold-seal film that dominated medical packaging when sealing tooling costs were less competitive in prior years. This shift commands meaningfully higher unit cost than conventional cold-seal format given the enhanced testing and certification requirements involved. Converters report heat sealable orders now outpacing cold-seal orders across several major pharmaceutical manufacturer accounts tracked this cycle, a clear reversal from just a few years earlier across comparable launches. The cold seal films market is a useful reference point here, growing from USD 1.6 billion in 2025 to USD 2.97 billion by 2036 at a 5.8% CAGR, according to MMA.
Market Impact: Drives roughly 5% of demand








